Recurrence rates for patients with early-stage breast cancer treated with IOERT at a community hospital per the ASTRO consensus statement for APBI.

Venita L Williams,Tanuja Bhandari, Lillian J Chen,Lawrence D Wagman,Michele Carpenter,Jay K Harness,Rajesh Khanijou, Maher Gobran, Windy Olaya, Melissa I Carandang,Robert B Ash

Brachytherapy（2019）

引用 3|浏览6

暂无评分

摘要

Single-fraction IOERT results in a low rate of IBTR when strictly adhering to ASTRO criteria for APBI suitability. Standard dose WBR for unfavorable pathologic results after 2100 cGy IOERT is well tolerated.

查看译文

关键词

IOERT,APBI,Breast cancer,Recurrence,ASTRO guideline

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要